Q2 2025 · 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P.holdings as filed
Filed 2025-08-14 · accession 0001213900-25-076586
$5.51B
Reported value
124
Positions
2025-06-30
Period end
The Brief · DEERFIELD MANAGEMENT COMPANY, L.P. · Q2 2025
AI · grounded in 13F
Deerfield Management Company, L.P. established a new position in NUVL valued at $1.37B. The fund also initiated new stakes in OSCR for $249.77M and VTRS for $214.53M. Additional new positions include MERUS N V at $178.03M and CNC at $172.90M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $1.37B | 24.9% | 17,991,024 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $249.8M | 4.53% | 11,649,591 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $214.5M | 3.89% | 24,023,907 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $178.0M | 3.23% | 3,384,628 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $172.9M | 3.14% | 3,185,370 | Common | SOLE |
| 457985AM1 | IART 0.5 08/15/25 | INTEGRA LIFESCIENCES HLDGS C | $172.9M | 3.14% | 174,364,000 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $169.7M | 3.08% | 9,724,508 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $155.8M | 2.83% | 10,567,160 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $155.3M | 2.82% | 540,626 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $146.8M | 2.66% | 1,167,802 | Common | SOLE |
| 02043QAB3 | ALNY 1 09/15/27 | ALNYLAM PHARMACEUTICALS INC | $143.2M | 2.60% | 110,000,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $124.5M | 2.26% | 3,384,072 | Common | SOLE |
| 604749AB7 | MIRM 4 05/01/29 | MIRUM PHARMACEUTICALS INC | $124.2M | 2.25% | 70,000,000 | Common | SOLE |
| 112463104 | BKD | BROOKDALE SR LIVING INC | $106.9M | 1.94% | 15,362,264 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $105.1M | 1.91% | 2,962,338 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $104.4M | 1.89% | 4,306,264 | Common | SOLE |
| 00653Q102 | AHCO | ADAPTHEALTH CORP | $93.4M | 1.70% | 9,904,895 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $92.6M | 1.68% | 5,115,953 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $82.3M | 1.49% | 3,915,311 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $78.9M | 1.43% | 3,348,117 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $70.5M | 1.28% | 700,700 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $67.9M | 1.23% | 857,724 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $62.5M | 1.13% | 2,879,476 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $61.4M | 1.11% | 21,231,974 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $58.2M | 1.06% | 1,923,100 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $54.6M | 0.99% | 226,070 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $48.7M | 0.88% | 919,403 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $47.3M | 0.86% | 145,000 | Common | SOLE |
| 29332G102 | EHABUSD | ENHABIT INC | $46.1M | 0.84% | 4,779,864 | Common | SOLE |
| 15687V109 | CERT | CERTARA INC | $45.9M | 0.83% | 3,926,099 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $43.3M | 0.79% | 2,215,845 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $42.0M | 0.76% | 4,692,000 | Common | SOLE |
| 875372AD6 | TNDM 1.5 03/15/29 2024 | TANDEM DIABETES CARE INC | $38.5M | 0.70% | 40,000,000 | Common | SOLE |
| 207410101 | CNMD | CONMED CORP | $36.5M | 0.66% | 700,271 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $35.5M | 0.64% | 2,017,464 | Common | SOLE |
| 516544AB9 | LNTH 2.625 12/15/27 | LANTHEUS HLDGS INC | $32.1M | 0.58% | 25,255,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $29.0M | 0.53% | 3,855,552 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $28.9M | 0.52% | 686,931 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $28.9M | 0.52% | 1,014,577 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $28.5M | 0.52% | 653,000 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $27.6M | 0.50% | 1,000,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $27.1M | 0.49% | 2,067,320 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $26.6M | 0.48% | 2,749,712 | Common | SOLE |
| 45258DAB1 | IMCR 2.5 02/01/30 | IMMUNOCORE HLDGS PLC | $25.8M | 0.47% | 30,000,000 | Common | SOLE |
| 53802LAB8 | LIVN 2.5 03/15/29 | LIVANOVA PLC | $25.4M | 0.46% | 25,000,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $24.2M | 0.44% | 3,723,131 | Common | SOLE |
| 92276F100 | VTR | VENTAS INC | $22.4M | 0.41% | 354,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $20.1M | 0.37% | 1,616,778 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $19.0M | 0.34% | 2,640,215 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $18.2M | 0.33% | 6,710,429 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $18.2M | 0.33% | 140,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $18.2M | 0.33% | 7,964,000 | Common | SOLE |
| 98422EAB9 | XERS 8 07/15/28 | XERIS BIOPHARMA HOLDINGS INC | $17.7M | 0.32% | 10,500,000 | Common | SOLE |
| 08659B102 | BBNX | BETA BIONICS INC | $17.0M | 0.31% | 1,168,415 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $17.0M | 0.31% | 542,020 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $16.9M | 0.31% | 625,000 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $16.8M | 0.31% | 970,590 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $15.7M | 0.28% | 2,148,000 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $15.3M | 0.28% | 3,255,514 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $15.1M | 0.27% | 1,562,942 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $14.7M | 0.27% | 825,119 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $12.4M | 0.23% | 5,386,000 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $11.6M | 0.21% | 888,950 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $11.1M | 0.20% | 812,561 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $10.1M | 0.18% | 553,107 | Common | SOLE |
| 457985208 | IART | INTEGRA LIFESCIENCES HLDGS C | $9.8M | 0.18% | 794,865 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $9.2M | 0.17% | 613,665 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $7.8M | 0.14% | 4,941,565 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $7.7M | 0.14% | 373,407 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $7.3M | 0.13% | 225,000 | Common | SOLE |
| 68236X100 | TOI | THE ONCOLOGY INSTITUTE INC | $6.9M | 0.13% | 3,360,052 | Common | SOLE |
| 829214105 | SLP | SIMULATIONS PLUS INC | $6.2M | 0.11% | 354,089 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $5.6M | 0.10% | 500,000 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $5.3M | 0.10% | 531,163 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $4.9M | 0.09% | 1,890,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $4.8M | 0.09% | 342,558 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $3.7M | 0.07% | 1,882,654 | Common | SOLE |
| 38942Q202 | CALC | CALCIMEDICA INC | $2.1M | 0.04% | 1,300,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.5M | 0.03% | 1,055,192 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.4M | 0.03% | 583,913 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $1.1M | 0.02% | 2,494,108 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $876,595 | 0.02% | 23,827 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $742,296 | 0.01% | 92,787 | Common | SOLE |
| 83601L102 | SHC | SOTERA HEALTH CO | $503,091 | 0.01% | 45,242 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $450,300 | 0.01% | 6,328 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $371,401 | 0.01% | 916 | Common | SOLE |
| 902673102 | UFPT | UFP TECHNOLOGIES INC | $370,391 | 0.01% | 1,517 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $368,247 | 0.01% | 1,945 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $364,992 | 0.01% | 11,138 | Common | SOLE |
| 525558201 | LMAT | LEMAITRE VASCULAR INC | $346,235 | 0.01% | 4,169 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $332,639 | 0.01% | 15,486 | Common | SOLE |
| 194014502 | ENOV | ENOVIS CORPORATION | $321,973 | 0.01% | 10,267 | Common | SOLE |
| 635906100 | NHC | NATIONAL HEALTHCARE CORP | $313,111 | 0.01% | 2,926 | Common | SOLE |
| 23918K108 | DVA | DAVITA INC | $299,287 | 0.01% | 2,101 | Common | SOLE |
| 09062W204 | BLFS | BIOLIFE SOLUTIONS INC | $294,452 | 0.01% | 13,670 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $289,297 | 0.01% | 1,597 | Common | SOLE |
| 023436108 | AMED | AMEDISYS INC | $269,982 | 0.00% | 2,744 | Common | SOLE |
| 405024100 | HAE | HAEMONETICS CORP MASS | $263,299 | 0.00% | 3,529 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $255,769 | 0.00% | 1,623 | Common | SOLE |
| 602496101 | MDXG | MIMEDX GROUP INC | $240,435 | 0.00% | 39,351 | Common | SOLE |
| 58506Q109 | MEDP | MEDPACE HLDGS INC | $231,001 | 0.00% | 736 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $224,188 | 0.00% | 917 | Common | SOLE |
| 03209R103 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $219,934 | 0.00% | 9,579 | Common | SOLE |
| 74765K113 | QSIAW | QUANTUM SI INC | $217,000 | 0.00% | 333,333 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $213,640 | 0.00% | 1,805 | Common | SOLE |
| 221006109 | CRVL | CORVEL CORP | $204,841 | 0.00% | 1,993 | Common | SOLE |
| 98978V103 | ZTS | ZOETIS INC | $204,295 | 0.00% | 1,310 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $202,491 | 0.00% | 1,628 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $189,621 | 0.00% | 17,083 | Common | SOLE |
| 203668108 | CYH | COMMUNITY HEALTH SYS INC NEW | $189,390 | 0.00% | 55,703 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $158,636 | 0.00% | 16,388 | Common | SOLE |
| 69380Q107 | PACS | PACS GROUP INC | $147,559 | 0.00% | 11,421 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $130,866 | 0.00% | 11,301 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $105,421 | 0.00% | 22,574 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $85,706 | 0.00% | 1,506 | Common | SOLE |
| 68236X118 | TOIIW | THE ONCOLOGY INSTITUTE INC | $64,125 | 0.00% | 1,250,000 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $44,983 | 0.00% | 166,666 | Common | SOLE |
| 124155110 | BFLYW | BUTTERFLY NETWORK INC | $44,220 | 0.00% | 733,333 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $33,187 | 0.00% | 168 | Common | SOLE |
| 29089Q105 | EBS | EMERGENT BIOSOLUTIONS INC | $11,943 | 0.00% | 1,872 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $9,317 | 0.00% | 8,790 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $6,524 | 0.00% | 43 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,017 | 0.00% | 166,666 | Common | SOLE |
| 62855J104 | MYGN | MYRIAD GENETICS INC | $2,682 | 0.00% | 505 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.